Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuronesXPAR:NRO -3.06%96 Return-on-Tangible-Asset is 8.76% as of Dec. 2025, which is 14% above its 10-year median of 7.69. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.44 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 2,892 Software companies, Neurones ranks better than 70.09% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Neurones's annualizedNet Income for the quarter that ended in Dec. 2025 was €58.8 Mil. Neurones's average total tangible assets for the quarter that ended in Dec. 2025 was €670.8 Mil. Therefore, Neurones's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 8.76%.
The historical rank and industry rank for Neurones's Return-on-Tangible-Asset or its related term are showing as below:
XPAR:NRO'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.34 Med: 7.69 Max: 8.29
Current: 7.78
During the past 13 years, Neurones's highest Return-on-Tangible-Asset was 8.29%. The lowest was 6.34%. And the median was 7.69%.
XPAR:NRO's Return-on-Tangible-Asset is ranked better than 70.09% of 2892
companies
in the Software industry
Industry Median: 2.055
vs XPAR:NRO: 7.78
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Neurones Return-on-Tangible-Asset Related Terms
Neurones Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Neurones's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: Return-on-Tangible-Asset Comparison
For the Information Technology Services subindustry, Neurones's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones Return-on-Tangible-Asset vs Software Industry
For the Software industry and Technology sector, Neurones's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Neurones's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 8.76% mean?
Neurones (XPAR:NRO) has a Return-on-Tangible-Asset of 8.76% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Neurones and its competitors. This is 14% above median its historical median of 7.69. Over the past decade, Neurones' Return-on-Tangible-Asset has ranged from 6.34 to 8.29. According to the industry distribution chart, Neurones ranks #865 out of 2892 companies in the Software industry, placing it in the top 29.9%.
Is Neurones' Return-on-Tangible-Asset too high?
Neurones' current Return-on-Tangible-Asset of 8.76% is 14% above median its 10-year median of 7.69. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 8.29. The Software industry median Return-on-Tangible-Asset is 2.06. Neurones' value of 8.76% is 326.3% above this industry median. Based on the distribution chart, Neurones ranks #865 out of 2892 companies in the Software industry, which is above the industry midpoint. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Return-on-Tangible-Asset compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #865 out of 2892 companies for Return-on-Tangible-Asset. This puts Neurones in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.06. Neurones' value of 8.76% is 326.3% above this benchmark. Historically, Neurones' own Return-on-Tangible-Asset has ranged from 6.34 to 8.29 over the past decade. While the company's 10-year median is 7.69 vs. the industry median of 2.06, Neurones has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Software company?
The median Return-on-Tangible-Asset among Software companies is 2.06, based on 2,892 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current Return-on-Tangible-Asset of 8.76% is 326.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Neurones and its competitors. For the Software industry, the median Return-on-Tangible-Asset is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current Return-on-Tangible-Asset is 8.76%, which is 14% above median its own 10-year median of 7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.44, compared to a current price of €34.90 — trading 30.8% below its estimated fair value. The current Return-on-Tangible-Asset is 8.76%, which is 14% above median its 10-year median of 7.69 and 326.3% above the Software industry median of 2.06. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Return-on-Tangible-Asset is 8.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €34.90 is trading 30.8% below its estimated GF Value™ of €50.44.
GuruFocus considers Neurones to be Significantly Undervalued.
Key valuation signals for XPAR:NRO:
Return-on-Tangible-Asset: 8.76% (14% above median its 10-year median of 7.69)
GF Value™: €50.44 vs. price of €34.90 (30.8% below fair value)
Industry Position: 326.3% above the Software median (#865 of 2892)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
96GF Score
Get the complete analysis for XPAR:NRO
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
